[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IN2013MU03667A - - Google Patents

Info

Publication number
IN2013MU03667A
IN2013MU03667A IN3667MU2013A IN2013MU03667A IN 2013MU03667 A IN2013MU03667 A IN 2013MU03667A IN 3667MU2013 A IN3667MU2013 A IN 3667MU2013A IN 2013MU03667 A IN2013MU03667 A IN 2013MU03667A
Authority
IN
India
Prior art keywords
composition
relates
budesonide
salts
solid oral
Prior art date
Application number
Other languages
English (en)
Inventor
Ajmal Shareef
Ananda Haranath Uppala
Rahul Sudhakar Dabre
Girish Kumar Jain
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to PCT/IB2014/065914 priority Critical patent/WO2015071812A1/en
Priority to IN3667MU2013 priority patent/IN2013MU03667A/en
Publication of IN2013MU03667A publication Critical patent/IN2013MU03667A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3667MU2013 2013-11-18 2014-11-10 IN2013MU03667A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/065914 WO2015071812A1 (en) 2013-11-18 2014-11-10 Solid oral modified-release composition comprising budesonide or salt thereof
IN3667MU2013 IN2013MU03667A (es) 2013-11-21 2014-11-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3667MU2013 IN2013MU03667A (es) 2013-11-21 2014-11-10

Publications (1)

Publication Number Publication Date
IN2013MU03667A true IN2013MU03667A (es) 2015-07-31

Family

ID=54397630

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3667MU2013 IN2013MU03667A (es) 2013-11-18 2014-11-10

Country Status (1)

Country Link
IN (1) IN2013MU03667A (es)

Similar Documents

Publication Publication Date Title
ZA201708692B (en) Antibacterial compounds
WO2015160975A3 (en) Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer
CL2015002897A1 (es) Inhibidores de bace1
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
WO2016040814A3 (en) Disulfide polymers and methods of use
EP4385563A3 (en) Dosage forms and therapeutic uses l-4-chlorokynurenine
MX2019000677A (es) Células miméticas de células b.
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2017007027A (es) Antagonista de a2a de dosis baja para el tratamiento de tdah y la enfermedad de parkinson.
GB2527233A (en) Composition comprising hydrocortisone
WO2015044434A3 (de) FLUOR-9-METHYL-ß-CARBOLINE
IN2013MU02576A (es)
MX2016002502A (es) Composiciones farmaceuticas de bendamustina.
IN2013MU03611A (es)
IN2013MU03667A (es)
WO2017079403A3 (en) Polymeric nanoparticles
IN2013MU03668A (es)
IN2013MU03612A (es)
WO2016137266A3 (ko) 에페리손과 펠루비프로펜을 함유하는 약제학적 조성물
RU2014154366A (ru) Применение пробиотического штамма микроорганизма enterococcus faecium l3 для лечения нейродегенеративных заболеваний
MX2017007018A (es) Nanopartículas para encapsular compuestos, su preparación y sus usos.
MX2015007749A (es) Composicion farmaceutica de clorhidrato de amantadina-loratadina-p aracetamol para integrar una capsula, para el tratamiento de resfriados entre otras alopatias.
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.